Oral iron prophylaxis in pregnancy: not too little and not too much!

Nils Milman1

  • 1Department of Obstetrics, Næstved Hospital, DK-4700 Næstved, Denmark.

Journal of Pregnancy
|August 14, 2012
PubMed

Insights

Adequate iron intake during pregnancy prevents iron deficiency anemia (IDA) and supports fetal development. Recommended oral iron doses vary by country, with individualized approaches beneficial in developed nations.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Nutritional Science

Background:

  • Iron is crucial for fetal and newborn development, including brain function.
  • Iron deficiency anemia (IDA) in pregnancy is linked to preterm birth and low birth weight.
  • Maternal iron deficiency can lead to infants born with IDA.

Purpose of the Study:

  • To review the importance of iron supplementation during pregnancy.
  • To evaluate current recommendations for oral iron prophylaxis.
  • To discuss optimal iron dosing strategies based on socioeconomic context.

Main Methods:

  • Review of existing literature and guidelines on iron supplementation in pregnancy.
  • Analysis of recommended iron doses in different countries.
  • Consideration of individualized versus general prophylaxis approaches.

Main Results:

  • Oral iron prophylaxis effectively improves iron status and prevents IDA in pregnant women.
  • Current Danish guidelines recommend 40-50 mg ferrous iron daily.
  • Lower doses (30-40 mg) may suffice in affluent societies, while higher doses (≥60 mg) might be needed in developing countries based on population iron status.

Conclusions:

  • Iron supplementation is essential for pregnant women to prevent IDA and support healthy fetal development.
  • Individualized iron prophylaxis based on serum ferritin levels is advantageous in developed countries.
  • General iron prophylaxis with potentially higher doses is recommended for pregnant women in developing countries, considering local iron status.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

OverviewElements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally-occurring, and fewer still are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.The Periodic Table Provides Information...
The Periodic Table and Organismal Elements01:27

The Periodic Table and Organismal Elements

Elements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally occurring, and only a few of them are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.
Periodic Table Provides Information...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...